Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: Results from the nationwide French PREVENIR survey

Heart

Volumn 88, Issue 2, 2002, Pages 159-162

  Danchin, Nicolas ^a   Grenier, O ^a   Ferrieres J ^b   Cantet, C ^b   Cambou, J P ^b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; FEMALE; FRANCE; HEALTH SURVEY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION;

EID: 0036077462     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.2.159     Document Type: Article

References (16)

1. Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention
2. Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
3. Beta-blockade after myocardial infarction: Systematic review and meta regression analysis
4. ACE inhibitor use in patients with myocardial infarction: Summary of evidence from clinical trials
5. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study (4S)
7. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators
8. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
9. Aggressive lipid lowering therapy compared with angioplasty in stable coronary artery disease
10. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
11. Patients treated with invasive procedures for acute coronary syndromes receive more secondary prevention than patients treated conservatively. Results from ENACT
12. Prevention secondaire de la maladie coronaire en France. Résultats de l'étude EUROASPIRE, registre des cardiopathies ischémiques de Lille
13. Management of acute myocardial infarction in intensive care units in 1995: A nationwide French survey of practice and early hospital results
14. Trends in the post-hospitalization medical treatment of unstable angina pectoris: 1990 to 1995
15. A European Society of Cardiology survey of secondary coronary heart disease: Principal results. EUROASPIRE study group. Action on secondary prevention through intervention to reduce events
16. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: Data from the national registry of myocardial infarction 2